Abstract
Background
The secretion of biologically active estrogen through the conversion of circulating precursor androgens has been suggested to play important roles in the pathophysiology of estrogen-dependent carcinomas. In the present study, we examined aromatase expression in gastric carcinoma.
Methods
Nineteen specimens of gastric carcinoma were obtained from Japanese patients at the Department of Surgery, Tottori University Hospital, Japan. Nontumoral tissues adjacent to the carcinoma were also available for analysis. The histological features of the gastric carcinomas were as follows: 8 intestinal-type and 11 diffuse-type adenocarcinomas. Tissue specimens removed at surgery were used for the preparation of RNA or for immunohistochemical analysis. Six cell lines derived from human gastric cancers were also used as a model system. Using conventional and real-time reverse transcription-polymerase chain reactions, aromatase mRNA expression and promoter usage were assayed. Immunohistochemical analysis was performed using an anti-aromatase antibody.
Results
We demonstrated the molecular basis of aromatase mRNA expression, which depended on three proximal promoters in tumoral and nontumoral tissues, for the first time. The tumoral tissues exhibited positive staining for anti-aromatase antibody. At the same time, positive staining was also observed in nontumoral mucosa, predominantly in the parietal cells.
Conclusion
We provide evidence suggesting a mechanism for the secretion of estrogen through the conversion of a precursor androgen in tumoral and nontumoral tissues in the stomach.
Article PDF
Similar content being viewed by others
References
Katzenellenbogen BS. Estrogen receptors: bioactivities and interactions with cell signaling pathways. Biol Reprod 1996;54:287–293.
Izawa M, Yeh J. Apoptosis in human reproductive tissues: emerging concepts. Reprod Med Rev 1997;6:23–36.
Lephart ED. A review of brain aromatase cytochrome P450. Brain Res Rev 1996;22:1–26.
Ackerman GE, Smith ME, Mendelson CR, MacDonald PC, Simpson ER. Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture. J Clin Endocrinol Metab 1981;53:412–417.
Harada N, Sasano H, Murakami H, Ohkuma T, Nagura H, Takagi Y. Localized expression of aromatase in human vascular tissues. Circ Res 1999;84:1285–12891.
Mackay A, Urruticoechea A, Dixon JM, Dexter T, Fenwick K, Ashworth A, et al. Molecular response to aromatase inhibitor treatment in primary breast cancer. Breast Cancer Res 2007;9:R37.
Bulun SE, Chen D, Lu M, Zhao H, Chen Y, Demura M, et al. Aromatase excess in cancers of breast, endometrium and ovary. J Steroid Biochem Mol Biol 2007;106:81–96.
Tokunaga A, Nishi K, Matsukura N. Estrogen and progesterone receptors in gastric cancer. Cancer 1986;57:1376–1379.
Matsuyama S, Ohkura Y, Eguchi H, Kobayashi Y, Akagi K, Uchida K, et al. Estrogen receptor β is expressed in human stomach adenocarcinoma. J Cancer Res Clin Oncol 2002;128:319–324.
Zhao XH, Gu SZ, Liu SX, Pan BR. Expression of estrogen receptor and estrogen receptor messenger RNA in gastric carcinoma tissues. World J Gastroenterol 2003;9:665–669.
Wang M, Pan JY, Song GR, Chen HB, An LJ, Sx Q. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters. Eur J Surg Oncol 2007;33:195–201.
Saitoh Y, Sasano H, Naganuma H, Ohtani H, Sasano N, Ohuchi A, et al. De novo expression of aromatase in gastric carcinoma, light and electron microscopic immunohistochemical and immunoblot study. Pathol Res Pract 1992;188:53–60.
Ueyama T, Shirasawa N, Numazawa M, Yamada K, Shelangousky M, Ito T, et al. Gastric parietal cells: potent endocrine role in secreting estrogen as a possible regulator of gastro-hepatic axis. Endocrinology 2002;143:3162–3170.
Hojo H. Establishment of cultured cell lines of human stomach cancer origin and their morphological characteristics (in Japanese). Niigata Igakkai Zasshi (Niigata Med J) 1977;9:281–285.
Sekiguchi K, Sakakibara M, Fujii G. Establishment of cultured cell lines derived from a human gastric carcinoma Jpn J Exp Med 1978;48:61–68.
Owen-Schaub L-B, Radinsky R, Kruzel E, Berr K, Yonehara S. Anti-Fas antibody on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res 1994;54:1580–1586.
Yanagihara K, Seyama T, Tsumuraya M, Kamada N, Yokoro K. Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene. Cancer Res 1991;51:381–386.
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–254.
Okubo T, Mok SC, Chen S. Regulation of aromatase expression in human ovarian surface epithelial cells. J Clin Endocrinol Metab 2000;85:4889–4899.
Turner KJ, Macpherson S, Miller MR, McNeilly AS, Williams K, Cranfield M, et al. Development and validation of a new monoclonal antibody to mammalian aromatase. J Endocrinol 2002;172:21–30.
Coen P, Kulin H, Ballantinee T, Zaino R, Frauenhoffer E, Boal D, et al. An aromatase-producing sex-cord tumor resulting in prepubertal gynecomastia. N Engl J Med 1991;324:317–322.
Braunstein GD. Aromatase and gynecomastia. Endocr Relat Cancer 1999;6:315–324.
Rosai J. Breast disease in males. In: Rosai J, editor. Surgical pathology, vol. 2. 2nd ed. New York: Mosby; 2004. p. 1837–1839.
Izawa M, Harada T, Taniguchi F, Ohama Y, Takenaka Y, Terakawa N. An epigenetic disorder may cause aberrant expression of aromatase gene in endometriotic stromal cells. Fertil Steril 2007 (in press).
Kousteni S, Bellido T, Plotkin LI, O’Brien CA, Bodenner DL, Han L, et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 2001;104:719–730.
Izawa M, Teramachi K. Down-regulation of protein kinase C activity by sorbitol rapidly induces apoptosis in human gastric cancer cell lines. Apoptosis 2001;6:353–358.
Izawa M, Mori M, Satoh T, Teramachi K, Sairenji T. Identification of an alternative form of caspase-9 in human gastric cancer cell lines: a role of a caspase-9 variant in apoptosis resistance. Apoptosis 1999;4:321–325.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Izawa, M., Inoue, M., Osaki, M. et al. Cytochrome P450 aromatase gene (CYP19) expression in gastric cancer. Gastric Cancer 11, 103–110 (2008). https://doi.org/10.1007/s10120-008-0463-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10120-008-0463-x